2025 Partners
Expertise Partner: WuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling around 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."
Innovation Partner: Lino Biotech AG
Lino Biotech AG, a Miltenyi Biotec Company, advances drug discovery with its label-free focal Molography platform, enabling real-time, multiplexed biomolecular interaction analysis in complex biological samples like human serum and living cells. By measuring interactions in their native environment, its MACS® Matchmaker system delivers precise kinetic and affinity data, especially for high-throughput DNA-encoded library (DEL) hit validation. From antibody screening to GPCR analysis, we provide high-sensitivity solutions that accelerate therapeutic development with unmatched biological relevance.
Exhibition Partner: Gator Bio
Gator Bio is a Silicon Valley biotech company with a mission to help biopharma scientists gain research insights faster. We fused engineering and science expertise to create novel analytical technologies that achieve better performance and more convenient solutions at a fraction of the cost of existing products. This is the biolayer interferometry solution you've been waiting for.
Event Partner: Curia
Curia is a global Contract Development and Manufacturing Organization with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing to make treatments broadly accessible to patients. Our Small Molecules offering spans discovery to commercial manufacturing and fill-finish services, integrating scientific, process, regulatory and analytical capabilities. Curia’s scalable technologies and dedicated teams advance your program through drug substance and drug product manufacturing.
From curiosity to cure, we are your trusted ally to accelerate life-changing therapeutics. To learn more visit us at https://curiaglobal.com/small-molecules/
Exhibition Partner: SAI Life Sciences
Sai Life Sciences is the fastest-growing contract research, development, and manufacturing organisation (CRDMO) among listed Indian peers (in terms of revenue CAGR as well as EBITDA CAGR from FY22 to FY24). As a pure-play, full-service CRDMO, we work with over 280 global innovator pharma and biotech companies to accelerate the discovery, development, and commercialisation of their NCE small molecule programmes.
Over the past 25 years, Sai Life Sciences has served a diverse set of programmes, consistently delivering value based on its quality and responsiveness. As of March 2024, we had 2845 employees across our facilities in India, UK, USA and Japan.